| |
Home »
News » 02/06
» Eli Lilly to withdraw advice leaflet
Eli Lilly to withdraw advice leaflet
Date published: 16/02/2006
The
Medicines and Healthcare products Regulatory
Agency (MHRA) has forced Eli Lilly to
withdraw an advice leaflet. The leaflet, providing doctors with advice on
treatments for mental health, was written on behalf of
Diabetes UK and carried the logo of
the charity, reports the Financial Times.
However, Eli Lilly admitted
that it omitted to include that it had sponsored the leaflet, calling the
mistake an oversight. The firm was also criticised for not making the risk of
schizophrenia medicines clear, including its own drug Zyprexa (olanzapine), to
people suffering from hyperglycaemia and diabetes. The MHRA has called for Eli
Lilly to withdraw the information, originally distributed in 2003, although it
was removed in May last year by the firm.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to
the quality, accuracy, timeliness, completeness or fitness for a particular
purpose of this briefing. AllAboutMedicalSales will not be liable for any
claims, penalties, losses, damages, costs, or expenses arising from the use of
or inability to use this briefing or from any unauthorised access to or
alteration of the Briefing. AllAboutMedicalSales makes no warranty that the
contents of this briefing are compatible with all computer systems and
browsers.
|
